Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp

Bullboard Posts

Post by aebestaceyon Jul 15, 2018 7:58pm

303 Views

Post# 28318943

From News Wire:

Several readers and posters here have been seeking an explanation about the luke-warm reaction to the news last month that Canada will be officially legalizing cannabis in October.

One of the most difficult lessons for investors is figuring out what's priced in, and it's important to remember that legalization was widely expected.

Another factor may be the slight delay, as the October 17th date was 45-60 days further out than most had expected. Weighing beyond this "sell the news" factor, though, are several dynamics, including supply of shares and a proliferation of new LPs.

In recent weeks, the market has absorbed several large offerings, including $100 million from CannTrust, $17 million from Emerald Health and $52 million from Newstrike in May and $259 million from Aphria and $600 million from Canopy Growth (convertible notes) in June.

Heavy selling early in the year also weighed on the market.

Maybe the market may be beginning to factor in concerns about a less-than-robust rollout of retail cannabis this Fall due to constrained inventories and few stores open in key provinces like Quebec and Ontario.

Some recent news:

5 States Expected to Legalize Cannabis by 2020

Aurora Cannabis Acquires CannaRoyalty Pre-Roll Technology License for $7 Million

British Columbia Names 31 Initial Cannabis Suppliers

Canadian Medical Cannabis Patient Growth Slows

Here Are Four Cannabis Companies Actively Hiring New Team Members

Hiku Brands to Join Canopy Growth and Abandons WeedMD Acquisition

Kush Bottles Q3 Revenue Grows 173% to $12.9 Million

New CEO Highlights TGOD’s Opportunities

Newly Public Green Thumb Industries Raises C$80.3 Million Selling Shares at C$11.00

Supreme Cannabis Doubles Production Capacity to 10 Million Grams with Health Canada Approval

Tilray NASDAQ IPO Values Company Near $1.5 Billion

The Benzinga Cannabis Capital Conference is the premier gathering of cannabis entrepreneurs and investors in North America. Held at Arcadian, 401 Bay St, Toronto, ON M5H 2Y4, Canada on August 16-17, 2018.